Last month’s performance of -6.17% for Agilon Health Inc (AGL) is certainly impressive

On Monday, Agilon Health Inc (NYSE: AGL) opened higher 9.24% from the last session, before settling in for the closing price of $6.82. Price fluctuations for AGL have ranged from $5.63 to $29.44 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Annual sales at Healthcare sector company grew by 50.52% over the past five years. Company’s average yearly earnings per share was noted -11.99% at the time writing. With a float of $299.26 million, this company’s outstanding shares have now reached $412.38 million.

Agilon Health Inc (AGL) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Agilon Health Inc is 26.30%, while institutional ownership is 87.53%. The most recent insider transaction that took place on Nov 29, was worth 250,206. In this transaction Director of this company bought 22,300 shares at a rate of $11.22, taking the stock ownership to the 31,931 shares. Before that another transaction happened on Sep 13, when Company’s Chief Markets Officer sold 18,750 for $18.00, making the entire transaction worth $337,455. This insider now owns 79,543 shares in total.

Agilon Health Inc (AGL) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.59 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -11.99% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

Check out the current performance indicators for Agilon Health Inc (AGL). In the past quarter, the stock posted a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.72.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.22, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.06 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Agilon Health Inc (NYSE: AGL) saw its 5-day average volume 6.02 million, a negative change from its year-to-date volume of 7.51 million. As of the previous 9 days, the stock’s Stochastic %D was 87.87%. Additionally, its Average True Range was 0.57.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 12.35%, which indicates a significant decrease from 96.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.94% in the past 14 days, which was higher than the 88.16% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $9.40, while its 200-day Moving Average is $16.06. Nevertheless, the first resistance level for the watch stands at $7.68 in the near term. At $7.92, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.32. If the price goes on to break the first support level at $7.05, it is likely to go to the next support level at $6.65. The third support level lies at $6.42 if the price breaches the second support level.

Agilon Health Inc (NYSE: AGL) Key Stats

There are currently 406,041K shares outstanding in the company with a market cap of 3.02 billion. Presently, the company’s annual sales total 2,708 M according to its annual income of -106,550 K. Last quarter, the company’s sales amounted to 1,216 M and its income totaled -31,440 K.